Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson Annual Health for Humanity Investor Webcast Transcript

Jun 18, 2020 / 12:00PM GMT
Release Date Price: €127.32 (-1.27%)
Christopher DelOrefice
Johnson & Johnson - VP of IR

Hello. This is Chris DelOrefice, Vice President of Investor Relations, and it is my pleasure to welcome you to our third Health for Humanity webcast to review Johnson & Johnson's sustainability progress in 2019 and share insights into our goals going forward. We provide this forum to augment our Health for Humanity Report that was published this month and is available on our website at investor.jnj.com.

Before we discuss the topics highlighted in our 2019 Health for Humanity Report, I want to address how Johnson & Johnson is engaging in the dialogue and responding to the issue of racism and discrimination that is a significant focal point across the United States. Alex Gorsky addressed all employees, stating unequivocally that racism and discrimination in any form is unacceptable and that black lives matter. This is reflective of our credo and how we value all our employees. We believe each and every employee must be provided an inclusive work environment where they are considered an individual. We must respect their diversity and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot